We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+0.42%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.12B
AUM Growth
+$762M
Cap. Flow
+$908M
Cap. Flow %
14.82%
Top 10 Hldgs %
15.76%
Holding
794
New
208
Increased
110
Reduced
107
Closed
121

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$85M
2
ABT icon
Abbott
ABT
+$72M
3
NVDA icon
NVIDIA
NVDA
+$60.9M
4
TER icon
Teradyne
TER
+$52.2M
5
LEGN icon
Legend Biotech
LEGN
+$50.2M

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$98.7M
2
TXN icon
Texas Instruments
TXN
+$95.4M
3
GPN icon
Global Payments
GPN
+$54.3M
4
JNJ icon
Johnson & Johnson
JNJ
+$49.4M
5
KLAC icon
KLA
KLAC
+$49M

Sector Composition

Rank Sector Weight
1 Healthcare 46.26%
2 Technology 25.67%
3 Communication Services 8.98%
4 Financials 5.47%
5 Consumer Staples 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATH
226
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$6.26M 0.1%
+90,860
New +$6.04M
S icon
227
SentinelOne
S
$7.25B
$6.25M 0.1%
116,668
– –
EWTX icon
228
Edgewise Therapeutics
EWTX
$4.84B
$6.01M 0.1%
361,821
+7,332
+2% +$133K
KNTE
229
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$5.99M 0.1%
260,276
– –
NGCA
230
DELISTED
NextGen Acquisition Corp. II Class A Ordinary Shares
NGCA
$5.95M 0.1%
+600,000
New +$5.94M
HCIC
231
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$5.92M 0.1%
600,002
– –
INSM icon
232
Insmed
INSM
$21.8B
$5.89M 0.1%
213,968
-182,583
-46% -$4.79M
AGGR
233
DELISTED
Agile Growth Corp
AGGR
$5.82M 0.1%
599,999
– –
GWH icon
234
ESS Tech
GWH
$21.5M
$5.8M 0.09%
38,660
+20,649
+115% +$3.08M
CERE
235
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$5.76M 0.09%
195,331
+51,619
+36% +$1.45M
OLPX
236
DELISTED
Olaplex Holdings
OLPX
$5.72M 0.09%
+233,335
New +$5.72M
STMP
237
DELISTED
Stamps.com, Inc.
STMP
$5.71M 0.09%
+17,314
New +$5.49M
PRAX icon
238
Praxis Precision Medicines
PRAX
$8.82B
$5.71M 0.09%
20,583
-3,180
-13% -$863K
TBIO
239
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$5.64M 0.09%
28,162
+723
+3% +$183K
BHVN
240
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$5.63M 0.09%
40,515
-81,893
-67% -$10.2M
CDNS icon
241
Cadence Design Systems
CDNS
$92.6B
$5.41M 0.09%
+35,700
New +$5.44M
TSP
242
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$5.38M 0.09%
144,874
– –
SCR
243
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
$5.38M 0.09%
157,132
+58,497
+59% +$1.62M
AUR icon
244
Aurora
AUR
$13.2B
$5.31M 0.09%
534,607
-1,465,393
-73% -$14.5M
XLNX
245
DELISTED
Xilinx Inc
XLNX
$5.28M 0.09%
+34,960
New +$5.12M
CRL icon
246
Charles River Laboratories
CRL
$12.5B
$5.13M 0.08%
12,426
-23,450
-65% -$9.74M
BLSA
247
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$5.11M 0.08%
512,616
– –
KURA icon
248
Kura Oncology
KURA
$826M
$5.01M 0.08%
267,683
– –
NVST icon
249
Envista
NVST
$4.54B
$5M 0.08%
+119,592
New +$5.04M
BOLT icon
250
Bolt Biotherapeutics
BOLT
$7.71M
$4.99M 0.08%
19,717
+633
+3% +$179K
8 9
10
11 12

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Woodline Partners held 794 positions worth $6.12B, up 14% from $5.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners deployed $908M of net new capital in Q3 2021, opening 208 new positions and adding to 110 existing holdings. Its largest new stake was Qualcomm: 599,018 shares worth $77.3M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Amphenol, an estimated $98.7M trimmed.

  • Woodline Partners's largest Q3 2021 buy was Qualcomm: 599,018 shares worth $77.3M.
  • Woodline Partners added most to Teradyne in Q3 2021, an estimated $52.2M increase.
  • Woodline Partners's biggest Q3 2021 reduction was Amphenol, cutting an estimated $98.7M.
  • Woodline Partners fully exited Boston Scientific in Q3 2021, selling an estimated $44.9M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.12B portfolio in Q3 2021.
  • Woodline Partners opened 208 new positions and closed 121 in Q3 2021.
  • Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.12B.

Based on Woodline Partners's 13F filing for Q3 2021, filed 15 Nov 2021.